Metabonomics based NMR in Crohn's disease applying PLS-DA

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue SUPPL., 2013, Pages

  Fathi, Fariba ^a   Oskouie, Afsaneh Arefi ^b   Tafazzoli, Mohsen ^a   Naderi, Nosratollah ^b   Sohrabzedeh, Kaveh ^c   Fathi, Soraya ^d   Norouzinia, Mohsen ^b   Nejad, Mohammad Rostami ^b  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Electrical Engineer Golpayegan Payam University   (Iran)

^d KHARAZMI UNIVERSITY   (Iran)

Author keywords

(1H NMR); Crohn's disease; Metabonomics; PLS DA

Indexed keywords

BIOLOGICAL MARKER; LIPID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; HUMAN; LIPID BLOOD LEVEL; METABOLITE; METABOLOMICS; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84888799471     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baumgart D, Carding S. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-40.
2. Baumgart D, Sandborn W. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57.
3. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
4. German JB, Hammock BD, Watkins SM. Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 2005;1:3-9.
5. Nicholson J, Lindon J, Holmes E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;29:1181-89.
6. Hong Y-S, Hong KS, Park M-H, Ahn Y-T, Lee J-H, Huh C-S, et al. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J Clin Gastroenterol 2011:415-25.
7. Bezabeh T, Somorjai RL, Smith ICP. MR metabolomics of fecal extracts: applications in the study of bowel diseases. Magn Reson Chem 2009;47:54-61.
8. Gall GL, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, et al. Metabolomics of Fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 2011;10:4208-18.
9. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, et al. Quantitative metabolomic profiling of serum, plasma, and urine by 1H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res 2012;11:3344-57.
10. Fathi F, Kyani A, Rostami Nejad M, Rezaye-Tavirani M, Naderi N, Zali MR, et al. A metabonomics study on Crohn's disease using nuclear magnetic resonance spectroscopy. HealthMED 2012;6:3577-84.
11. Fathi F, Tafazzoli M, Mehrpour M, Shahidi G. Study of metabolic profiling Parkinson's disease. HealthMED 2013; 7:204-10.
12. Barker M, Rayens W. Partial least squares for discrimination. J Chemometr 2003;17:166-73.
13. Ramadan Z, Jacobs D, Grigorov M, Kochhar S. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta 2006;68:1683-91.
14. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 1995;67: 793-811.
15. Fan M. Metabolite profiling by one- and twodimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc 1996;28:161-219.
16. Lindon JC. NMR Spectroscopy on biofluids. Annu Rep NMR Spectrosc 1999;38:1-88.
17. Kohavi R, Provost F. Glossary of Terms. Machine Learning 1998;30:271-74.
18. Hrabovsky V, Zadak Z, Blaha V, Hyspler R, Ticha A, Karlik T. Lipid metabolism in active crohn's disease: pre-results. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006;150:363-66.
19. Kuroki F, Iida M, Tominaga M, Matsumoto T, Kanamoto K, Fujishima M. Is vitamin E depleted in Crohn's disease at initial diagnosis? Dig Dis 1994;12:248-54.
20. Rubinstein HM, Dietz AA, Srinivasan R. Relation of vitaminE and serumlipids. Clin Chim Acta 1969;23:1-6.
21. Horwitt MK, Harvey CC, Dahm CHJ, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972;203:223-36.
22. Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989;84:744-48.
23. Kuroki F, Iida M, Tominaga M, Matsumoto T, Hirakawa K, Sugiyama S, et al. Multiple vitamin status in Crohn's disease; correlation with disease activity. Dig Dis Sci 1993;38:1614-18.